Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1Phase 1/2 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 38Thoracic 31Genitourinary 21Breast 20Gastrointestinal 15Head & Neck 8Dermatologic 7Gynecologic 4Sarcoma 2Other solid neoplasm 2Lymphoid 2Plasma cell 1Other hematologic neoplasm 1Endocrine 1CNS 1

Conditions

Ovarian Neoplasms 57Carcinoma, Ovarian Epithelial 28Fallopian Tube Neoplasms 20Uterine Cervical Neoplasms 17Endometrial Neoplasms 17Breast Neoplasms 13Stomach Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Lung Neoplasms 9Prostatic Neoplasms 8Squamous Cell Carcinoma of Head and Neck 7Parkinson Disease 4, Autosomal Dominant Lewy Body 7Esophageal Neoplasms 7Carcinoma, Renal Cell 7Peritoneal Neoplasms 6Melanoma 6Uterine Neoplasms 4Urinary Bladder Neoplasms 4Small Cell Lung Carcinoma 4Sarcoma 4Pancreatic Neoplasms 4Neoplasms 4Head and Neck Neoplasms 4Esthesioneuroblastoma, Olfactory 4Colorectal Neoplasms 4Carcinoma, Transitional Cell 4Triple Negative Breast Neoplasms 3Salivary Gland Neoplasms 3Kidney Neoplasms 3Brenner Tumor 3

Interventions

Paclitaxel 28Carboplatin 28pembrolizumab 25Bevacizumab 14liposomal doxorubicin 12Cisplatin 11Gemcitabine 10Radiotherapy 8Drug Therapy 8Cyclophosphamide 8Blood Specimen Collection 8Topotecan 7Nivolumab 7olaparib 6Doxorubicin 6niraparib 5Therapeutics 5Dexamethasone 5pertuzumab 4pazopanib 4lenvatinib 4fludarabine 4cemiplimab 4atezolizumab 4Trastuzumab 4Surveys and Questionnaires 4Psychiatric Rehabilitation 4Polymerase Chain Reaction 4Fulvestrant 4Docetaxel 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Neoplasms × Docetaxel × Gynecologic × Clear all
NCT05714553 2025-07-18

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

NuCana plc

Phase 1/2 Terminated
19 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Esophageal Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT02922764 2025-03-26

A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer

Inspirna, Inc.

Phase 1 Completed
146 enrolled
GynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Endometrial Neoplasms, Small Cell Lung Carcinoma

NCT02009449 2024-11-15

IVY

Eli Lilly and Company

Phase 1 Completed
353 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT00758732 2015-09-28

Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma

Hellenic Oncology Research Group

Phase 2 Terminated
34 enrolled
Gynecologic

Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡